Longevity eye cream
US-2024423898-A1 · Dec 26, 2024 · US
Modulation of thymosin beta-4 in skin
US9114089B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9114089-B2 |
| Application number | US-201314100514-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 9, 2013 |
| Priority date | Dec 13, 2011 |
| Publication date | Aug 25, 2015 |
| Grant date | Aug 25, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment of skin.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for cosmetically improving the aesthetic appearance of human skin comprising topically applying to an area of the human skin in need thereof a composition comprising a cosmetically a effective amount of a synthetic compound selected from the group consisting of: and combinations thereof for a time sufficient to cosmetically improve the aes…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9114089B2 cover?
- Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents, other than a retinoid, that stimulate thymosin beta-4 expression in the skin. Also provided are methods for screening for substances which stimulate thymosin beta-4 expression levels and the methods of using active agents identified by the screening protocol in the treatment …
- Who is the assignee on this patent?
- Avon Prod Inc
- What technology area does this patent fall under?
- Primary CPC classification A61Q19/08. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).